Free Trial

NIOX Group (NIOX) Competitors

NIOX Group logo
GBX 70 -0.20 (-0.28%)
As of 08/1/2025 12:04 PM Eastern

NIOX vs. SN, EKF, CREO, IUG, NCYT, IHC, POLX, AVO, RUA, and MHC

Should you be buying NIOX Group stock or one of its competitors? The main competitors of NIOX Group include Smith & Nephew (SN), EKF Diagnostics (EKF), Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Inspiration Healthcare Group (IHC), Polarean Imaging (POLX), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), and MyHealthChecked (MHC). These companies are all part of the "medical devices" industry.

NIOX Group vs. Its Competitors

Smith & Nephew (LON:SN) and NIOX Group (LON:NIOX) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

In the previous week, Smith & Nephew and Smith & Nephew both had 1 articles in the media. NIOX Group's average media sentiment score of 0.68 beat Smith & Nephew's score of 0.00 indicating that NIOX Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Smith & Nephew
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
NIOX Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Smith & Nephew presently has a consensus target price of GBX 7,840, suggesting a potential upside of 577.91%. NIOX Group has a consensus target price of GBX 90, suggesting a potential upside of 28.57%. Given Smith & Nephew's higher possible upside, equities analysts plainly believe Smith & Nephew is more favorable than NIOX Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Smith & Nephew
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
NIOX Group
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Smith & Nephew has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, NIOX Group has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500.

NIOX Group has a net margin of 28.21% compared to Smith & Nephew's net margin of 5.41%. NIOX Group's return on equity of 13.29% beat Smith & Nephew's return on equity.

Company Net Margins Return on Equity Return on Assets
Smith & Nephew5.41% 5.85% 4.51%
NIOX Group 28.21%13.29%3.95%

Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.5%. NIOX Group pays an annual dividend of GBX 1 per share and has a dividend yield of 1.4%. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. NIOX Group pays out 4,126.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Smith & Nephew is clearly the better dividend stock, given its higher yield and lower payout ratio.

NIOX Group has lower revenue, but higher earnings than Smith & Nephew. Smith & Nephew is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smith & Nephew£7.08B1.79£382.79M£27.7741.64
NIOX Group£3.53B8.14£995.88M£0.022,888.78

62.2% of Smith & Nephew shares are held by institutional investors. Comparatively, 35.2% of NIOX Group shares are held by institutional investors. 0.2% of Smith & Nephew shares are held by insiders. Comparatively, 46.7% of NIOX Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

NIOX Group beats Smith & Nephew on 8 of the 15 factors compared between the two stocks.

Get NIOX Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for NIOX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NIOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NIOX vs. The Competition

MetricNIOX GroupMedical Devices IndustryMedical SectorLON Exchange
Market Cap£28.75B£3.48B£5.47B£3.03B
Dividend Yield1.66%2.44%4.74%5.02%
P/E Ratio2,888.7877.0828.67176.74
Price / Sales8.14101.45422.31264,367.13
Price / Cash11.2115.9935.4527.97
Price / Book3.883.948.274.54
Net Income£995.88M£132.05M£3.24B£5.90B
7 Day Performance1.45%-2.84%-3.63%-0.92%
1 Month Performance3.24%3.43%4.40%6.15%
1 Year Performance9.38%8.15%25.97%71.63%

NIOX Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NIOX
NIOX Group
2.4161 of 5 stars
GBX 70
-0.3%
GBX 90
+28.6%
+11.1%£28.75B£3.53B2,888.7892News Coverage
SN
Smith & Nephew
3.475 of 5 stars
GBX 1,180
+0.8%
GBX 7,840
+564.4%
+5.1%£12.94B£7.08B42.4818,452News Coverage
High Trading Volume
EKF
EKF Diagnostics
N/AGBX 30.48
+4.4%
N/A+12.6%£135.48M£49.91M28.37356News Coverage
CREO
Creo Medical Group
N/AGBX 13.25
-1.0%
N/A-58.9%£53.55M£33.87M-2.10279
IUG
Intelligent Ultrasound Group
N/AN/AN/AN/A£42.76M£6.57M-18.9165
NCYT
Novacyt
N/AGBX 39.58
-0.8%
N/A-11.6%£27.35M£18.12M-0.73120News Coverage
Gap Up
IHC
Inspiration Healthcare Group
N/AGBX 22
+2.3%
N/A-24.4%£19.06M£42.87M-1.51224
POLX
Polarean Imaging
N/AGBX 1.06
-1.9%
N/A-41.5%£15.48M£5.21M-0.2728Gap Down
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
RUA
RUA Life Sciences
N/AGBX 11.28
-4.0%
N/A+7.1%£7.00M£4.05M-2.6348
MHC
MyHealthChecked
N/AGBX 12
-4.0%
N/A+25.4%£6.24M£9.43M-5.9916Gap Up

Related Companies and Tools


This page (LON:NIOX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners